Cogent Biosciences, Inc. <COGT.O>: Guggenheim raises target price to $52 from $45
COGT•Related News
Oklahoma Heart Institute joins national cardiovascular trials, uses Supira pVAD in SUPPORT II study
ARDT•
Nova management to attend Citi Global Technology Conference fireside chat
NVMI•
Kalaris Therapeutics Q2 net loss narrows on lower administrative costs
KLRS•
Hims & Hers Health Inc <HIMS.N>: Morgan Stanley raises target price to $28.00 from $21.00
HIMS•
Trading platform eToro beats profit estimates, targets US growth with TradeZero buy
ETOR•